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Accepted 13 January 2016Dermatoﬁbrosarcoma Protuberans (DFSP) represents a low grade, locally aggressive mesenchymal neoplasm
with characteristic clinicopathologic, immunohistochemical, and molecular ﬁndings. Myxoid DFSP is an uncom-
mon variant, with only few cases reported in the literature andmay present a diagnostic challenge on histopath-
ologic examination. We report the ﬁrst case of myxoid DFSP arising in the scrotum of a 38 year-old man and
describe the morphologic and immunohistochemical ﬁndings. Recognition of this variant at unusual sites is clin-
ically important because the differential diagnosis includes benign and malignant tumors which could lead to
under or over-treatment.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Dermatoﬁbrosarcoma Protruberans (DFSP) is a superﬁcial, low
grade locally aggressive mesenchymal neoplasm of ﬁbroblastic origin
which arises in the dermis and frequently involves the subcutaneous
tissues. It arises most commonly in the trunk, extremities, and head
and neck but may involve any body site [1]. Although it can occur at
any age, it typically presents in young to middle-aged adults, with a
peak incidence in the fourth decade of life. Cytogenetically, DFSP is char-
acterized by an identical t(17;22)(q22;q13) translocation, with some
cases resulting in a ring chromosome, forming a chimeric COL1A1-
PDGB gene [2], which plays an important role in DFSP pathogenesis
[3]. The typical histologic feature of DFSP is a storiform proliferation of
bland spindle shaped cells inﬁltrating the subcutaneous fat in a honey-
comb pattern, however a wide morphologic spectrum can be observed.
Several histologic variants are recognized including pigmented DFSP
(Bednar tumor), ﬁbrosarcomatous DFSP, myxoid DFSP, ﬂat atrophic
DFSP, giant cell ﬁbroblastoma, and DFSP with myogenic differentiation
[4–8].
Myxoid DFSP represents a rare morphologic variant with prominent
myxoid stromal changes that may cause considerable diagnostic chal-
lenges, particularly in the distinction from other more clinically aggres-
sive myxoid mesenchymal neoplasms. To the best of our knowledge,tah).
. This is an open access article underthis is the ﬁrst case of myxoid DFSP involving the scrotum.We describe
the morphologic and immunohistochemical ﬁndings and discuss the
differential diagnosis of this rare variant.2. Materials and methods
2.1. Case report
A 38 year-old man with a long-standing history of perineal
hidradenitis, presented to the Urology clinic complaining of an enlarg-
ing, painless, left scrotal mass that was originally the size of a golf ball
and had gradually increased in size over a period of two years. As part
of the workup, an ultrasound of the pelvis was performed which
showed a mass in the left paratesticular area. A decision was made to
surgically excise the mass.
Intraoperatively, two left scrotal masses, discrete from the testes,
were identiﬁed and excised, each measuring 5.0 cm in greatest dimen-
sion. An area of hidradenitis along the left hemiscrotum, measuring
7.0 cm in greatest dimension was also identiﬁed and resected.2.2. Histology and immunohistochemistry
Tissue sections were ﬁxed in 10% neutral buffered formalin, embed-
ded in parafﬁn, sectioned at 4-μm thickness, and stainedwith hematox-
ylin and eosin. The immunohistochemistry was performed and
evaluated at Wayne State University (Detroit Medical Center, Detroit,
MI), where the Ventana BenchMark Autostainer (Ventana Medical Sys-
tem, Tucson, Arizona) was used on 4-μm thick formalin-ﬁxed and
deparafﬁnized sectionswith the followingmarkers: CD34, smoothmus-
cle actin, AE1/AE3, desmin, S100, CD31 and MUC4.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 2. A. and B. High power magniﬁcation showing uniform spindle shaped cells with
spindle shaped nuclei (400×). C. Myoid balls identiﬁed surrounding blood vessels
(100×). D. Tumor cells were diffusely positive for CD34 (40×).
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3.1. Gross and microscopy
Grossly, the specimen consisted of tan–yellow soft tissue, partially
covered by skin that was remarkable for four raised nodular areas rang-
ing in size from 0.6 cmup to 1.5 cm. Sectioning revealed two pink–gray,
well circumscribed ﬂeshy masses measuring 5.5 × 4.8 × 3.0 cm and 5.0
× 4.5 × 3.7 cm that appeared to be connected resulting in a dumbbell-
shaped mass with an overall measurement of 10.5 × 4.8 × 3.7 cm. Cut
surfaceswere gelatinous and tan–gray. Histologic examination revealed
an ill-deﬁned lesionwith an inﬁltrative pattern of growth, involving the
dermis and extending into the subcutaneous tissues and present at the
resection margin. The lesion was variable in cellularity with relatively
hypocellular areas with myxoid stroma and numerous thin-walled
blood vessels, alternating with hypercellular areas forming a storiform
pattern (Fig. 1). Cytologically, the cells were low grade, spindle shaped,
relatively uniform with oval hyperchromatic nuclei and inconspicious
nucleoli. Occasional mitotic ﬁgures were seen. Myoid balls were identi-
ﬁed surrounding blood vessels (Fig. 2). In some sections, the overlying
skin was remarkable for features of Hidradenitis suppurativa including
heavy neutrophilic and mixed inﬂammatory inﬁltrate around apocrine
glands as well as sinus tracts with marked acute inﬂammation, abscess
formation and occasionally lined by granulation tissue.
3.2. Immunohistochemistry
The tumor cells were diffusely positive for CD34 and smoothmuscle
actin but were negative for cytokeratin, ALK-1, desmin, S100, CD31 and
MUC4 immunostains (Table 1).
Based on the morphology and immunophenotype, a diagnosis of
myxoid DFSP was rendered. The patient is now few months post sur-
gery with no evidence of disease.
4. Discussion
Myxoid DFSP was ﬁrst described by Freirson and Cooper in 1983 [8],
who reported two cases of myxoid DFSP that showed distinctive histo-
logic features including a monotonous haphazard arrangement of
spindle-shaped and stellate tumor cellswith little variation in cellularity
from ﬁeld to ﬁeld, pale basophilic stroma containing hyaluronic acid,Fig. 1. A. The tumor extends from dermis into subcutaneous adipose tissue with trapping
of fat in a “honeycomb” pattern (40×). B. The tumor consists of a relatively hypocellular
myxoid areas alternating with more cellular areas (40×). C. Delicate, thin-walled vessels
were frequently present within the myxoid stroma (100×). D. The relatively
hypercellular area consisting of spindle-shaped cells forming a storiform pattern (100×).minimal cytologic pleomorphism and a low mitotic rate with a dis-
persed, non-patterned vasculature.
The largest reported series to date included 23 cases of myxoid DFSP
arising in different locations, with the most common site being the ex-
tremities, followed by the head and neck but none in the scrotum [9].
The age and sex distribution was similar to typical DFSP [2], with a
wide age distribution, ranging from 9 months to 72 years (median
40 years) and approximately equal sex distribution. Moreover, Mentzel
et al. [10], reported a series of eight cases ofmyxoidDFSP,with amedian
age of 51 years with the majority involving the inguinal region. In our
case, the age at presentation was 38 years, similar to the previous stud-
ies, however, the tumor involved the scrotum, an unusual site not pre-
viously reported in the literature.
Distinctive histologic features of myxoid DFSP, present in our case,
include myxoid stroma and prominent thin-walled vessels, alternating
with relatively hypercellular areas forming a storiform pattern. Cells
were embedded in the myxoid stroma in a haphazard pattern and had
a spindle appearance with indistinct nucleoli. The tumor displayed a
strikingly inﬁltrative growth pattern,with trapping of the subcutaneous
adipose tissue in the characteristic honeycombmanner also observed in
typical DFSP. Additionally, myoid balls were identiﬁed surrounding
blood vessels. Reimann and Fletcher [9] deﬁned myxoid DFSP as DFSP
with greater than 50% myxoid stroma. In agreement with this ﬁnding,
more than 60% of the tumor in our case showed prominentmyxoid stro-
mal changes. Immunohistochemically, in addition to the characteristic
and diagnostic CD34 expression, expression of SMA was noted. These
ﬁndings are consistent with the immunohistochemical proﬁle of typical
DFSP [11]. Tumor cells were negative for cytokeratin, ALK-1, desmin,
S100, CD31 and MUC4 immunostains, which was helpful in supporting
the diagnosis of myxoid DFSP.
The histologic differential diagnosis of myxoid DFSP is diverse and
includes benign and malignant tumors. Among the benign tumors, su-
perﬁcial angiomyxoma, myxoid neuroﬁbroma, superﬁcial acralt1:1Table 1
t1:2Panel of antibodies used in this study.
t1:3Antibody Source/Clone Dilution Result
t1:4Cytokeratin DAKO/AE1AE3 1:500 Negative
t1:5SMA DAKO/1A4 1:400 Positive
t1:6S100 DAKO/polyclonal 1:1000 Negative
t1:7CD34 Immunotech 1:100 Positive
t1:8Desmin DAKO/D33 1:100 Negative
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considered. Superﬁcial angiomyxoma can be difﬁcult to distinguish
from myxoid DFSP, particularly on a small biopsy, as both tumors have
a myxoid stroma rich in blood vessels and express CD34 on tumor
cells. However, typical cases of superﬁcial angiomyxoma tend to be
less cellular, have a lobular rather than the inﬁltrative growth pattern
seen inmyxoid DFSP and contain neutrophils aswell as epithelial struc-
tures in 25% of the cases [12].
Myxoid neuroﬁbroma can be distinguished from myxoid DFSP by
the presence of wavy buckled nuclei, intralesional axons and S-100 pos-
itivity. Other benign myxoid tumors, such as nodular fasciitis should be
considered in the differential diagnosis of myxoid DFSP as well. The
presence of a rapidly-growing, painful and hypercellular lesion in a
loose feathery tissue-culture-like myxoid background is a characteristic
ﬁnding. Red blood cell extravasation, keloid type collagen and chronic
inﬂammatory cells are also present and help differentiate it from
myxoid DFSP [13].
Superﬁcial acral ﬁbromyxoma represents an entity occurring pre-
dominantly on the hands and feet in a subungual location. Cases of su-
perﬁcial acral ﬁbromyxoma are composed of spindle-shaped tumor
cells arranged in bands and fascicles, set in a varyingmyxoid and collag-
enous stroma [14].
Solitary ﬁbrous tumor, a distinct mesenchymal neoplasmwith CD34
positivity, may also show prominent myxoid stromal changes. Howev-
er, these neoplasms tend to be well-circumscribed, with varying cellu-
larity, a hemangiopericytoma-like vascular pattern, and CD99 and bcl-
2 immunoreactivity, a pattern not seen inmyxoid DFSP.Molecular anal-
yses have discovered that almost all solitary ﬁbrous tumors harbor an
NAB2-STAT6 fusion gene, with recent studies suggesting the use of
STAT6 immunohistochemistry as a reliable surrogate [15].
Malignant tumors, which may be confused with myxoid DFSP in-
clude low- grade ﬁbromyxoid sarcoma, low grade myxoﬁbrosarcoma
and myxoid liposarcoma. Given the presence of variable cellularity
with prominent vasculature, low-grade ﬁbromyxoid sarcoma is includ-
ed in the differential diagnosis of myxoid DFSP. These tumors arise
mainly in deep soft tissues butmay also involve the dermis and subcutis.
In contrast to myxoid DFSP, low-grade ﬁbromxoid sarcoma is a well-
circumscribed neoplasm with pushing margins and is composed of cy-
tologically bland tumor cells set in a variable myxoid and collagenous
stroma. Typically, delicate plexiform vasculature with perivascular scle-
rosis, hyalinizing rosettes, strong cytoplasmic stainingwithMUC4 and a
characteristic t(7;16)(q33;p11) are present in cases of low-grade
ﬁbromyxoid sarcoma [15,16].
Low grade myxoﬁbrosarcoma is characterized by the presence of a
multinodular growth pattern. Despite its low cellularity, the neoplastic
cells show a higher degree of cytologic atypia with enlarged and
hyperchromatic nuclei. Pseudolipoblasts and elongated, thin and curvi-
linear blood vessels are also present [17].
Myxoid liposarcoma is mainly seen in deep soft tissues of the thigh.
It rarely arises in a subcutaneous location. A mixture of atypical, small
and undifferentiated mesenchymal tumor cells and signet-ring
lipoblasts is usually seen in a prominent myxoid stroma with mucin
pooling. Unlike in myxoid DFSP, the vessels are delicate and arborizing.
Tumor cells are usually CD34 negative, S100 positive and show a char-
acteristic t(12;16)(q13;p11) in most cases [18].
At the molecular level, myxoid DFSP is characterized by the translo-
cation t(17;22)(q22;q13) resulting in PDGFB/COL1A1 fusion gene
which is detected in 85% of the cases andmay be an additional diagnos-
tic tool in cases of DFSP showing non-conclusive histologic features.
The prognosis of typical DFSP is generally excellentwhen completely
excised with clear margins [19]. Similarly, myxoid DFSP tends to have a
good prognosis with lowmetastatic potential; however, they are locally
aggressive with high rate of local recurrence following incomplete exci-
sion. Only 6 cases showed local recurrence among 33 reported caseswith available follow up [9]. The deﬁnitive treatment of DFSP is surgical
excision. Wide local excision with 3-cm margins yields less recurrence
than simple excision. Mohs micrographic surgery has also been used
for the surgical treatment of DFSP. Due to the precise and real-time
tumor mapping of this technique, maximal tissue sparing can be
achieved. Furthermore, this technique is more likely to yield complete
surgical clearancewithout recurrence, especially in tumorswithmyxoid
nature where it is usually difﬁcult to assess the status of the margin
grossly [20].
In summary, we report a case ofmyxoid DFSP involving the scrotum,
representing a rare variant of DFPS in an unreported location. Because of
its striking myxoid appearance, myxoid DFSP may present a diagnostic
challenge, particularly in small biopsies. Recognition of this variant is
clinically important because the differential diagnosis includes both be-
nign and malignant tumors, which could lead to undertreatment or
overtreatment, respectively.
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